Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Below 200 Day Moving Average - Time to Sell?

Key Points

• Advanced Medical Solutions Group's share price dropped below its 200-day moving average of GBX 204.18, trading as low as GBX 201.86 on Monday.
• Analysts from Berenberg Bank and Deutsche Bank both upgraded their ratings to "buy", with target prices set at GBX 300 and GBX 275 respectively.
• The company has a market capitalization of £442.76 million and a price-to-earnings ratio of 39.73, indicating investor expectations for growth.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report)'s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 204.18 ($2.76) and traded as low as GBX 201.86 ($2.73). Advanced Medical Solutions Group shares last traded at GBX 202 ($2.73), with a volume of 284,550 shares trading hands.

Analyst Ratings Changes

A number of brokerages recently weighed in on AMS. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a GBX 275 target price on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Berenberg Bank restated a "buy" rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Tuesday, July 15th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of GBX 287.50.

Advanced Medical Solutions Group Price Performance

The business has a 50-day moving average of GBX 206.08 and a 200 day moving average of GBX 204.27. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The firm has a market capitalization of £449.13 million, a P/E ratio of 40.31, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.